MRIGlobal
MRIGlobal is a renowned Midwest research institute based in Kansas City, dedicated to improving the overall health, safety, and well-being of people everywhere. With over 80 years of experience, MRIGlobal specializes in diagnostics, pharmaceutical sciences, vaccines and therapeutics, global health surveillance, infectious disease, public health, warfighter protection, agriculture, and management and operations. The organization is committed to using science and technology to create solutions for a safer, healthier, and more sustainable world.
MRIGlobal
425 Dr Martin Luther King Jr Blvd, Kansas City, MO 64110
What We Do
MRIGlobal has a long history of developing assays for use in drug development, clinical diagnostics, and environmental surveillance to investigate the presence, amount, or functional activity of target analytes.
MRIGlobal’s services span all stages of the diagnostic product development process, beginning with research and development for biological threat agent disease diagnostics.
MRIGlobal’s testing and evaluation supports chemical agent diagnostics assay, method, and platform developments.
The work performed in our clinical comparator laboratories supports EUA and 510(k) submission filings through FDA, accelerating product approvals and market access for our customers.
MRIGlobal creates new disease detection, diagnostics, vaccines, and therapeutics to arm public and private partners with the knowledge and technologies necessary to stay safe.
MRIGlobal improves patient treatment outcomes by advancing the diagnosis of antimicrobial resistance.
Biologics
Key People
News & Updates
An article discussing the insights of Dr. Gene Olinger on the spread and prevention of Monkeypox.
This article highlights MRIGlobal's role in supporting the first FDA-cleared over-the-counter COVID-19 test.
An article exploring the role of wastewater testing in tracking SARS-CoV-2 variants.